Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Borrell, Eulàlia ^a   Rodríguez, Mar ^b   Torán, Pere ^b,c   Muñoz, Laura ^c   Pera, Guillem ^c   Montellà, Núria ^a   Monteagudo, Mònica ^d   Urrea, Magalí ^c   Puigfel, Yolanda ^c   Negrete, Antonio ^b   Mezquiriz, Xavier ^a   Domènech, Cristina ^a   Lacasta, Anna ^a   García, Ma Llum ^a   Maneus, Sandra ^a   Tintoré, Glòria ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Catalan Health Institute   (Spain)

^c Primary Healthcare Research Support Unit Barcelones Nord i Maresme   (Spain)

^d Primary Healthcare Research Support   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG FUNCTION TEST; MALE; METHODOLOGY; MIDDLE AGED; MONITORING; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OBSERVATION; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; SMOKING; SPAIN; SURVIVAL RATE; TIME;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OBSERVATION; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; SPAIN; SURVIVAL RATE; TIME FACTORS;

EID: 60349085776     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-8     Document Type: Article

References (30)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. RA Pauwels AS Buist PM Calverley CR Jenkins SS Hurd GOLD Scientific Committee, Am J Respir Crit Care Med 2001 163 1256 76 11316667
2. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. VS Pẽa M Miravitlles R Gabriel CA Jiménez-Ruiz C Villasante JF Masa JL Viejo L Fernández-Fau, Chest 2000 118 981 9 10.1378/chest.118.4.981 11035667
3. Costs of chronic bronchitis and COPD: a 1-year follow-up study. M Miravitlles C Murio T Guerrero R Gisbert, Chest 2003 123 784 91 10.1378/chest.123.3.784 12628879
4. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. T Eaton S Withy JE Garrett J Mercer RM Whitlock HH Rea, Chest 1999 116 416 23 10.1378/chest.116.2.416 10453871
5. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. JJ Soler-Catalũa MA Martínez- García P Román-Sánchez E Salcedo M Navarro R Ochando, Thorax 2005 60 925 31 16055622 10.1136/thx.2005.040527
6. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. J Garcia-Aymerich E Farrero MA Félez J Izquierdo RM Marrades JM Antá on behalf of the EFRAM investigators, Thorax 2003 58 100 5 12554887 10.1136/thorax.58.2.100
7. Effect of social factors on winter hospital admission for respiratory disease: a case-control study of older people in the UK. RE Jordan JI Hawker JG Ayres P Adab W Tunnicliffe B Olowokure J Kai RJ McManus R Salter KK Cheng, Br J Gen Pract 2008 58 400 2 10.3399/bjgp08X302682 18505611
8. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis, DAFNE Study Group. M Miravitlles C Murio T Guerrero, Eur Respir J 2001 17 928 33 10.1183/09031936.01.17509280 11488328
9. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. SD Aaron KL Vandemheen JJ Clinch J Ahuja RJ Brison G Dickinson PC Hébert, Chest 2002 121 688 96 10.1378/chest.121.3.688 11888946
10. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. M Miravitlles M Ferrer A Pont R Zalacain JL Alvarez-Sala F Masa H Verea C Murio F Ros R Vidal IMPAC Study Group, Thorax 2004 59 387 95 15115864 10.1136/thx.2003.008730
11. COPD exacerbations: definitions and classifications. S Burge JA Wedzicha, Eur Respir J 2003 41 Suppl 46 53 10.1183/09031936.03.00078002
12. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. BR Celli W MacNee ATS/ERS Task Force, Eur Respir J 2004 23 932 46 10.1183/09031936.04.00014304 15219010
13. COPD exacerbations: the importance of a standard definition. R Pauwels P Calverley AS Buist S Rennard Y Fukuchi E Stahl CG Löfdahl, Respir Med 2004 98 99 107 10.1016/j.rmed.2003.09.001 14971871
14. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. R Kessler E Stahl C Vogelmeier J Haughney E Trudeau CG Löfdahl MR Partridge, Chest 2006 130 133 42 10.1378/chest.130.1.133 16840393
15. Memory for symptoms in COPD patients: how accurate are their reports? PM Meek SC Lareau D Anderson, Eur Respir J 2001 18 474 81 10.1183/09031936.01. 00083501 11589344
16. Exacerbations of chronic obstructive pulmonary disease. JA Wedzicha GC Donaldson, Respir Care 2003 48 1204 13 14651761
17. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. MC Zoia AG Corsico M Beccaria R Guarnone G Cervio R Testi MA Bressan E Pozzi I Cerveri, Respir Med 2005 99 1568 75 10.1016/j.rmed.2005.03.032 15890509
18. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. M Damarla BR Celli HX Mullerova VM Pinto-Plata, Respir Care 2006 51 1120 4 17005056
19. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. TM Wilkinson GC Donaldson JR Hurst TA Seemungal JA Wedzicha, Am J Respir Crit Care Med 2004 169 1298 303 10.1164/rccm.200310-1443OC 14990395
20. Epidemiology and treatment of chronic bronchitis and its exacerbations. P Ball, Chest 1995 108 Suppl 2 43 52 10.1378/chest.108.2-Supplement.43S
21. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. E Monsá J Ruiz A Rosell J Manterola J Fiz J Morera V Ausina, Am J Respir Crit Care Med 1995 152 1316 20 7551388
22. Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. G Viegi S Maio F Pistelli S Baldacci L Carrozzi, Respirology 2006 11 523 32 10.1111/j.1440-1843.2006.00886.x 16916323
23. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. C Llor J Molina K Naberan JM Cots F Ros M Miravitlles EVOCA study group, Int J Clin Pract 2008 62 585 92 10.1111/j.1742-1241.2008.01707.x 18266710
24. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2008). Global Initiative for Chronic Obstructive Lung Disease(GOLD) http://www.goldcopd.org
25. Standardized questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). CM Fletcher, BMJ 1960 2 1665 6 13688719
26. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to different language and culture: the Spanish example. M Ferrer J Alonso L Prieto V Plaza E Monsá R Marrades MC Aguar A Khalaf JM Antá Eur Respir J 1996 9 1160 6 10.1183/09031936.96.09061160 8804932
27. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, Am J Respir Crit Care Med 2002 166 111 7 12091180
28. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. J Bourbeau M Julien F Maltais M Rouleau A Beaupré R Bégin P Renzi D Nault E Borycki K Schwartzman R Singh JP Collet Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec, Arch Intern Med 2003 163 5 585 91 10.1001/archinte.163.5.585 12622605
29. KJ Rothman S Greenland, Modern Epidemiology Philadelphia: Lippincot-Raven 2 1998
30. [Recomendations for the care of the patient with chronic obstructive pulmonary disease]. J Alvarez-Sala E Cimas J Masa M Miravitlles J Molina K Naberan P Simonet J Viejo Grupo de Trabajo de la Sociedad Espãola de Neumología y Cirugía Torácica (SEPAR); Sociedad Espãola de Medicina de Familia y Comunitaria (semFYC), Arch Bronconeumol 2001 37 269 78 11481057